Preview

Medical Herald of the South of Russia

Advanced search

Immunological and epidemiological effectiveness of tularemia vaccination in the Donbass region

https://doi.org/10.21886/2219-8075-2023-14-4-66-76

Abstract

Objective: to evaluate the epidemiological and immunological efficacy of tularemia vaccination in the Donbass region from 1991 to the present.

Materials and methods: data on the incidence of tularemia, immunization coverage of the population, results of intradermal tests with tularin, agglutination reaction and indirect hemagglutination reaction with tularemia antigen were analyzed.

Results: since 2012, immunization against tularemia has not been carried out on the territory of the republic. Since 2015, this approach has resulted in the emergence of foci with multiple cases of human tularemia. Cases were registered on the territory of natural foci of Novoazovsky and Yasinovatsky districts. Since 2017, immunization of the population in enzootic territories has been resumed, planning and selection of contingents to be vaccinated was carried out in a differentiated manner. According to epidemic indications, 400 people were vaccinated from among those at risk of contracting tularemia. In 2020– 2022 vaccination was not carried out. In the five months of 2023, 520 people were vaccinated against tularemia, 80 people were revaccinated.

Conclusions: the use of tularemia vaccine in the Donetsk region for 70 years led to the containment of tularemia, demonstrating the epidemiological and immunological effectiveness of specific immunoprophylaxis. The armed conflict and the cessation of vaccination led to an increase in the activity of the epidemic process in natural foci among animals and a significant increase in the incidence of tularemia in humans.

About the Authors

O. A. Trunova
Donetsk National Medical University named after M. Gorky
DNR

Olga A. Trunova – Dr. Sci. (Med.), Professor; Professor of the Department of Organization of Higher Education, Health Management and Epidemiology

Donetsk


Competing Interests:

Авторы заявляют об отсутствии конфликта интересов



L. V. Skrypka
Center for Hygiene and Epidemiology of the DPR
DNR

Liliya V. Skrypka – Deputy Chief Physician for Antiepidemic Issues of the Federal Budgetary Institution of Health Care

Donetsk


Competing Interests:

Авторы заявляют об отсутствии конфликта интересов



A. E. Bagriy
Donetsk National Medical University named after M. Gorky
DNR

Andrey E. Bagriy – Dr. Sci. (Med.), Professor, head of the Department of internal medicine № 2

Donetsk


Competing Interests:

Авторы заявляют об отсутствии конфликта интересов



E. V. Prochorov
Donetsk National Medical University named after M. Gorky
DNR

Evgeniy V. Prochorov – Dr. Sci. (Med.), Professor, head of the Department of pediatrics № 1

Donetsk

 


Competing Interests:

Авторы заявляют об отсутствии конфликта интересов



N. A. Reznichenko
Medical Academy named after S.I. Georgievsky, V.I. Vernadsky Crimean Federal University
Russian Federation

Natalia A. Reznichenko – Dr. Sci. (Med.), Professor, professor of the Department of obstetrics, gynecology and perinatology № 1

Simferopol


Competing Interests:

Авторы заявляют об отсутствии конфликта интересов



References

1. Zaitsev A.A., Agapitov D.S., Gnusareva O.A., Ostapovich V.V., Sazonov A.V., Dubyansky V.M. The Analysis of Epidemiologic Risks of Tularemia in the Natural Focus of a Steppe Type in the Stavropol Krai in 2003-2018 and Ways of Their Minimization. Public Health and Life Environment – PH&LE. 2020;(3):52-56. (In Russ.) https://doi.org/10.35627/2219-5238/2020-324-3-52-56

2. European Centre for Disease Prevention and Control, European Food Safety Authority the European Union. One Health 2021 Zoonoses Report. EFSA Journal. 2022; 20(12):7666. https://doi.org/10.2903/j.efsa.2022.7666.

3. Yeni DK, Büyük F, Ashraf A, Shah MSUD. Tularemia: a reemerging tick-borne infectious disease. Folia Microbiol (Praha). 2021;66(1):1-14. https://doi.org/10.1007/s12223-020-00827-z

4. Snowden J, Simonsen KA. Tularemia. 2023 Jul 17. In: Stat-Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28613655.

5. Vetluzhskih A.A., Tokmakov V.S., Lantsov E.V. Materials According to Nozogeografiya of Mongolia: Tulyaremiya and Other Tick-Borne Zoonoz in the Gobi Desert. Bulletin of the Russian Military Medical Academy. 2018;S1:23-24. (In Russ.) eLIBRARY ID: 39152674

6. Putzova D, Senitkova I, Stulik J. Tularemia vaccines. Folia Microbiol (Praha). 2016;61(6):495-504. https://doi.org/10.1007/s12223-016-0461-z

7. Troha K, Božanić Urbančič N, Korva M, Avšič-Županc T, Battelino S, Vozel D. Vector-Borne Tularemia: A Re-Emerging Cause of Cervical Lymphadenopathy. Trop Med Infect Dis. 2022;7(8):189. https://doi.org/10.3390/tropicalmed7080189

8. Prokšová M, Bavlovič J, Klimentová J, Pejchal J, Stulík J. Tularemia – zoonosis carrying a potential risk of bioterrorism. Epidemiol Mikrobiol Imunol. 2019;68(2):82-89. PMID: 31398981.

9. Elkins KL, Kurtz SL, De Pascalis R. Progress, challenges, and opportunities in Francisella vaccine development. Expert Rev Vaccines. 2016;15(9):1183-96. https://doi.org/10.1586/14760584.2016.1170601

10. W allet P, Lagrange B, Henry T. Francisella Inflammasomes: Integrated Responses to a Cytosolic Stealth Bacterium. Curr Top Microbiol Immunol. 2016;397:229-56. https://doi.org/10.1007/978-3-319-41171-2_12

11. Jia Q, Horwitz MA. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. Front Cell Infect Microbiol. 2018;8:154. https://doi.org/10.3389/fcimb.2018.00154

12. Feodorova VA, Sayapina LV, Corbel MJ, Motin VL. Russian vaccines against especially dangerous bacterial pathogens. Emerg Microbes Infect. 2014;3(12):e86. https://doi.org/10.1038/emi.2014.82

13. Firstova V.V., Kalmantaeva О.V., Gorbatov А.А., Turin Е.А. Specific cellular reactions reflected antitularemia postvaccinal immunity. Bacteriology. 2016;1(1):102–108. https://doi.org/10.20953/2500-1027-2016-1-102-108

14. Rotem S, Cohen O, Bar-Haim E, Bar-On L, Ehrlich S, Shafferman A. Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes. PLoS One. 2014;9(1):e85215. https://doi.org/10.1371/journal.pone.0085215

15. Zvi A, Rotem S, Bar-Haim E, Cohen O, Shafferman A. Wholegenome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a Tcell response. PLoS One. 2011;6(5):e20050. https://doi.org/10.1371/journal.pone.0020050

16. Öhrman C, Sahl JW, Sjödin A, Uneklint I, Ballard R, et al. Reorganized Genomic Taxonomy of Francisellaceae Enables Design of Robust Environmental PCR Assays for Detection of Francisella tularensis. Microorganisms. 2021;9(1):146. https://doi.org/10.3390/microorganisms9010146

17. Golovliov I, Bäckman S, Granberg M, Salomonsson E, Lundmark E, et al. Long-Term Survival of Virulent Tularemia Pathogens outside a Host in Conditions That Mimic Natural Aquatic Environments. Appl Environ Microbiol. 2021;87(6):e02713-20. https://doi.org/10.1128/AEM.02713-20

18. Eneslätt K, Rietz C, Rydén P, Stöven S, House RV, et al. Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis. Eur J Immunol. 2011;41(4):974-80. https://doi.org/10.1002/eji.201040923

19. Aronova NV, Onoprienko NN, Tsimbalistova MV, Pavlovich NV. [Comparative analysis of parameters of humoral and cell specific immunity in individuals immunized with a live tularemia vaccine]. Zh Mikrobiol Epidemiol Immunobiol. 2014;(5):32-7. (In Russ.) PMID: 25536768.

20. Tärnvik A, Ericsson M, Golovliov I, Sandström G, Sjöstedt A. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol Med Microbiol. 1996;13(3):221-5. https://doi.org/10.1111/j.1574-695X.1996.tb00242.x

21. Savel'eva RA, Ananova EV, Pronin AV, Fominykh EA, Rodionova IV. Opredelenie prodolzhitel'nosti postvaktsinal'nogo immuniteta protiv tuliaremii [The determination of the duration of postvaccinal immunity against tularemia]. Zh Mikrobiol Epidemiol Immunobiol. 1995;(6):51-2. (In Russ.) PMID: 8553755


Review

For citations:


Trunova O.A., Skrypka L.V., Bagriy A.E., Prochorov E.V., Reznichenko N.A. Immunological and epidemiological effectiveness of tularemia vaccination in the Donbass region. Medical Herald of the South of Russia. 2023;14(4):66-76. (In Russ.) https://doi.org/10.21886/2219-8075-2023-14-4-66-76

Views: 655


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2219-8075 (Print)
ISSN 2618-7876 (Online)